Clinical trial
A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle
NCT03028415 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 28, 2017
- Completion date
- July 9, 2020
- Enrollment
- 56 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.
arthrodesis surgery involving the hindfoot or ankle